The WavelinQ™ EndoAVF System offers physicians a non-surgical alternative for AV fistula creation. Using two thin, flexible, magnetic catheters and a burst of RF energy, proceduralists can create an endovascular AV fistula.




The WavelinQ™ EndoAVF System is indicated for the creation of an arteriovenous fistula (AVF) using concomitant ulnar artery and ulnar vein or concomitant radial artery and radial vein in patients with minimum artery and vein diameters of 2.0 mm at the fistula creation site who have chronic kidney disease and need hemodialysis.


How It Works

The catheters are each inserted into an artery (brachial) and a vein (brachial, ulnar or radial) in the arm through a small puncture or incision. Using fluoroscopy, the catheters are both advanced to the appropriate location for endovascular AV fistula creation (ulnar artery-ulnar vein or radial artery-radial vein). The magnets in the catheters allow them to be precisely aligned while pulling the two adjacent vessels closer together. The venous catheter, which contains the electrode, delivers a burst of RF energy to create a connection between the artery and the vein.


1 Access

Two thin, flexible, magnetic catheters are inserted into an artery and vein in the arm through small punctures or incisions.


2 Alignment

When placed in proximity, the magnets in each catheter attract to each other, pulling the vessels together and aligning the RF electrode.


3 Activation

The venous catheter, which contains the electrode, delivers a burst of RF energy to create a connection between the artery and vein. Then, the catheters are removed.


4 Completion

A brachial vein embolization is then recommended to divert more flow through the perforator to the superficial veins (cephalic, median cubital and/or basilic veins) for hemodialysis.

Clinical Experience

Clinical studies of WavelinQ™ EndoAVF System evaluated safety and effectiveness of the device. Below are findings from the studies.


SAE: Serious Adverse Event as adjudicated by the CEC, reported at any time during follow-up.3

88 of 91 subjects in the 4F Global Analysis had a successful endoAVF creation at 6 months.

Procedure Success: Successful endoAVF creation confirmed via intraprocedural fistulography or by duplex ultrasound performed post-procedure. 

Reinterventions: Secondary procedures performed after the index procedure.

Read The Global Data Analysis

Data from the EASE (n=32), EASE-2 (n=24) and the EUR Post-Market (n=35) studies of the WavelinQ™ 4F EndoAVF System was aggregated and analyzed in the 4F Global Analysis (n=91). See the WavelinQ™ EndoAVF System Instructions for Use for the full analysis, including more details on each of the studies.

BD data on file. Clinical Study Report

Training and Support

An effective endoAVF program requires a multidisciplinary commitment to the patient journey. BD will be there with training, support, resources and tools to help you establish an endoAVF program.


Vascular Lab Readiness
EndoAVF Vein Mapping

Professional Ultrasound Training

Our specialized endovascular fistula teams help educate and train the ultrasound team on vein mapping for WavelinQ™ EndoAVF.

Professional Ultrasound Training


EndoAVF Creation
EndoAVF Follow Up

Hands-on Physician Training

Our expert physician trainers conduct procedural training using a mix of virtual technologies, simulators and hands-on demonstrations and our local certified specialists in-service the full procedure team, proctor initial cases and follow up.

Hands-on Physician Training


Dialysis Center Readiness
EndoAVF Cannulation

EndoAVF Cannulation Training

Our specialized dialysis team helps prepare dialysis centers for endoAVF cannulation.

EndoAVF Cannulation Training

Procedural Resources


Physician payment may be available for Endovascular Arteriovenous Fistula (EndoAVF) procedures using HCPCS level II code G2171.

Please contact your local Medicare Administrative Contractor (MAC) for payment rates assigned to your specific location.



The WavelinQ™ EndoAVF System Reimbursement Hotline is available to answer your questions.

Hotline hours are Monday – Friday from 9 am to 5 pm EST. The hotline can be reached via phone or email.

(844) 337-2670  |

Any email or voicemail will be returned within 24 business hours. For information on physician billing, please contact your respective professional society.

Reimbursement Resources

Sign Up For More Information

Learn more about how you can offer more options for your ESKD patients with WavelinQ™ EndoAVF System.

1 Device-Related SAE: Adverse Event related to study device
2 Procedure-Related SAE: Adverse Event that occurred during index procedure
3 Serious Adverse Events (SAE): If an event results in the following, it is automatically an SAE:
• Led to a death; or
• Led to serious deterioration in the health of the subject, that either resulted in:
• A life-threatening illness or injury;
• A permanent impairment of a body structure or a body function;
• In-patient or prolonged existing hospitalization;

Becton, Dickinson and Company does not guarantee that the use of any code will ensure coverage or payment at any particular level. Medicare, Medicaid or other payers may implement policies differently in various sections of the country. Physicians and hospitals should confirm with a particular payer or coding authority, such as the American Medical Association or medical specialty society, which codes or combinations of codes are appropriate for a particular procedure or combination of procedures. Reimbursement for a product or procedure can be different depending upon the setting in which the product is used. Coverage and payment policies can also change over time making the information provided herein obsolete.